Centre may grant indemnity to COVID vaccine manufacturers Pfizer and Moderna: Sources
Granting indemnity is like giving a concessional request of legal protection from any claims linked to the use of their Covid-19 vaccines in India. India has so far not given an indemnity to any COVID vaccine manufacturer against the costs of compensation for any severe side effects so far.
Jun 02, 2021, 12:03 PM IST
B1617 variant spreading worldwide at 'frightening speed': Experts
The B1617 COVID-19 variant is spreading worldwide at 'frightening speed' and could aggravate the pandemic -- particularly in countries with low vaccination rates, according to the latest assessment of the virus by experts here.
Jun 01, 2021, 13:02 PM IST
Centre creating 'artificial scarcity' of COVID-19 vaccines to benefit Bharat Biotech, SII, says AAP
AAP spokesperson Atishi said the government's vaccine drive has stopped in schools and this is the case throughout the country while in private hospitals, vaccination is still going on at different rates.
May 28, 2021, 16:52 PM IST
Pfizer tells Centre its vaccine suitable for 12 years and above, ready to provide 50 crore doses
US pharmaceutical giant Pfizer has said that is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions. However, the US drugmaker has asked for relaxations in some clauses, including indemnification for its shots, sources informed.
May 27, 2021, 07:49 AM IST
William Shakespeare, man who got first-ever jab of COVID-19 vaccine, dies at 81
William Shakespeare, the man who was hit the headlines last year for becoming the first-ever man to get a jab against COVID-19, died of an unrelated illness at the age of 81.
May 26, 2021, 15:21 PM IST
Moderna to launch single-dose COVID-19 vaccine in India in 2022, Pfizer ready to offer 5 crore doses this year
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday.
May 26, 2021, 06:43 AM IST
Will supply COVID-19 vaccine only to central governments, supranational organisations: Pfizer
The company said that it is having discussions with the Indian government to start the supply of Pfizer-BioNTech vaccine in the country.
May 24, 2021, 17:50 PM IST
Bharat Biotech applies for WHO approval, pre-submission meeting soon
Hyderabad based Bharat Biotech has submitted an application to the WHO for Emergency Use Listing(EUL), becoming the 2nd made in India vaccine to apply at the global body for authorization.
May 24, 2021, 15:25 PM IST
Arvind Kejriwal appeals to Centre to import COVID-19 vaccines after Pfizer, Moderna refuse to directly sell to Delhi govt
"Pfizer and Moderna have said that they will deal with the Government of India alone," Kejriwal said.
May 24, 2021, 13:10 PM IST
Israel to lift COVID-19 restrictions as it succeeds in vaccine rollout
After a successful vaccine rollout, Israel is all set to remove its COVID-19 restrictions. The country has vaccinated 92 percent of its population aged 50 and more.
May 24, 2021, 11:34 AM IST
Moderna rejected request for direct supply of coronavirus vaccines: Punjab govt
World's leading vaccine manufacturer, Moderna Inc. has declined a request for a direct supply of vaccines by the Punjab state government.
May 23, 2021, 19:40 PM IST
Oxford, Pfizer vaccines 80% effective against COVID-19 variant found in India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
May 22, 2021, 22:40 PM IST
Japan gives green signal to AstraZeneca, Moderna COVID-19 vaccines
After the BioNTech Pfizer's COVID-19 vaccine, the Japanese government allows the use of Oxford AstraZeneca and Moderna vaccines for inoculation against coronavirus disease.
May 21, 2021, 14:52 PM IST
COVID-19: European Union to reopen borders for fully vaccinated travellers
The European Union is considering to reopen its borders for non-essential travels for the people who have completed their vaccination against COVID-19.
May 21, 2021, 10:58 AM IST
US to become vaccine sharing leader, pledges to share 80 million COVID-19 vaccine jabs globally
US President Joe Biden announced that the United States will share 80 million vaccine doses globally over the next six weeks. The 80 million doses will include 20 million doses of the Moderna, Pfizer and Johnson & Johnson vaccines as well as AstraZeneca.
May 18, 2021, 12:09 PM IST
Japan to allow use of Moderna for vaccination against COVID-19
Amid the surge in COVID-19 cases, Japan is ready to allow the use of the Moderna vaccine against COVID-19. Currently, only the Pfizer vaccine is being used in Japan for inoculation.
May 18, 2021, 09:09 AM IST
COVID-19: US CDC allows use of Pfizer vaccine for 12-15 years old
An advisory panel of the Centres for Disease Control and Prevention recommended the use of the Pfizer-BioNTech COVID-19 vaccine for children aged between 12 and 15 in the US.
May 13, 2021, 08:43 AM IST
COVID-19: US authorises Pfizer-BioNTech vaccine shot for children aged between 12 and 15
President Joe Biden said that it is a promising development in United States' fight against coronavirus.
May 11, 2021, 06:50 AM IST
COVID jabs for kids aged 2 to 11: Pfizer to seek approval in Sept
Pharmaceutical major Pfizer will likely seek the US Food and Drug Administration's emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, the media reported.
May 05, 2021, 16:08 PM IST
COVID-19: There is no concern over safety of vaccine, Pfizer tells India
"Safety and efficacy data had been backed by regulatory authorities in the US, Britain, Japan and WHO - agencies that India endorses," a company spokeswoman said.
May 04, 2021, 07:26 AM IST
